Identification of pathogenic macrophages in breast cancer as markers of tumor aggressiveness. Background: In RIBBON-1, the combination of Bev with Cap as 1st-line therapy for MBC significantly ...
Prospective study of fatigue and metabolic parameters in patients with early breast cancer (EBC) receiving concomitant radiotherapy and anthracycline-based adjuvant chemotherapy No significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results